Fundus Autofluorescence Change as an Early Indicator of Treatment Effect of Brachytherapy for Choroidal Melanomas | Zendy

Jesintha Navaratnam | Zendy; Thomas P. Bærland | Zendy; Nils Eide | Zendy; Rowan Thomas Faber | Zendy; B.L. Rekstad | Zendy; Demetrios G. Vavvas | Zendy; Ragnheiður Bragadóttir | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Fundus Autofluorescence Change as an Early Indicator of Treatment Effect of Brachytherapy for Choroidal Melanomas

Author(s) -

Jesintha Navaratnam,

Thomas P. Bærland,

Nils Eide,

Rowan Thomas Faber,

B.L. Rekstad,

Demetrios G. Vavvas,

Ragnheiður Bragadóttir

Publication year - 2019

Publication title -

ocular oncology and pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.444

H-Index - 10

eISSN - 2296-4681

pISSN - 2296-4657

DOI - 10.1159/000499403

Subject(s) - medicine , nuclear medicine , choroidal melanoma , retinal pigment epithelium , atrophy , ophthalmology , pathology , retinal , melanoma , cancer research

Early confirmation of the effect of brachytherapy for choroidal melanoma showing that tumour coverage is valuable. The irradiated retinal pigment epithelium (RPE) commonly develops atrophy. This study compares the fundus autofluorescence (AF) changes to the development of RPE atrophy following brachytherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research